The 16th World ADC San Diego, held from November 3–6, 2025, brought together industry leaders in San Diego, USA. Dr. Ting Xu, Founder, Chairman, and CEO of Alphamab Oncology, was invited to deliver a ...
Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.
Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under ...
Linvoseltamab (LINVO) + bortezomib (BTZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): First results from the LINKER-MM2 trial. Belantamab ...
Optimizing icIEF identifies mAbs more accurately, while staying within European Pharmacopoeia and ICH guidelines.
Analyzing charge variants of biopharmaceuticals is a critical component of product development and quality control. Charge variants commonly occur as a result of both chemical and post-translational ...
AID systems were associated with varying glycemic outcomes in type 1 diabetes, with MiniMed 780G users demonstrating best time in range.